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5ABSTRACT
The incidence of type 2 diabetes is increasing worldwide, mainly because of increas-
ing life expectancy and changes in lifestyle. However, several other factors may also 
increase the risk of type 2 diabetes and their importance at a longer follow-up are not 
well explored. People living with diabetes have an increased risk of stroke but there 
are still gaps in knowledge about the excess risk at different risk factor levels. The fi rst 
purpose of this thesis was to explore two risk factors for type 2 diabetes, high-normal 
blood pressure and low socioeconomic position defi ned by occupation, based on data 
from the Multifactor Primary Prevention study in Gothenburg. The second aim was to 
estimate the excess risk of stroke in people with type 2 diabetes in respect to their blood 
pressure level and in people with type 1 diabetes in respect to their metabolic control 
measured by HbA1c. For these studies, data on people with diabetes were collected 
from the National Diabetes Register and the excess risk of stroke was compared to 
controls from the general population. 
Out of 7494 middle aged men in Gothenburg examined in 1970-1973 and followed 
until the end of 2011, 13% had a registered diagnosis of diabetes mellitus at any time. 
Men with systolic blood pressure 130-139 mmHg (high-normal blood pressure) at the 
screening examination had a 43% increased risk of developing diabetes compared to 
men with systolic blood pressure below 130 mmHg. Men in the lowest occupational 
class had a signifi cantly increased risk of diabetes compared to men in the highest occu-
pational class even after adjusting for stress and several other risk factors for diabetes. 
The conditional probability of developing diabetes after 35 years taking death attribut-
able to other causes into account was 43% in the lowest occupational class compared to 
23% in the highest occupational class.  
As a group, people with type 2 diabetes had an increased risk of stroke compared to the 
risk of the general population. When the risk was estimated at different blood pressure 
levels, the increased risk of ischemic stroke at all blood pressure levels was offset by a 
signifi cant reduced risk of hemorrhagic stroke at lower blood pressure levels. Therefore 
people with type 2 diabetes and a blood pressure below 130/80 mmHg had a risk of 
stroke comparable to the general population.
The risk of stroke was increased for people with type 1 diabetes in all HbA1c categories 
compared to the general population. However, the risk rose from 75% excess in risk for 
people with type 1 diabetes and good metabolic control to an eightfold excess in risk for 
the least well controlled group. HbA1c was more important as a risk factor for ischemic 
compared to hemorrhagic stroke in people with type 1 diabetes. 
In conclusion, this thesis showed that high-normal blood pressure and low occupational 
class remain as risk factors for type 2 diabetes even after an extended follow-up into 
older ages. People with type 2 diabetes and low blood pressure have a risk of stroke 
comparable to the general population. The thesis also underlines the importance of as-
sisting people with type 1 diabetes in every possible way to maintain a good metabolic 
control in order reduce the risk of stroke.
Keywords: type 2 diabetes, type 1 diabetes, stroke, high-normal blood pressure, 
occupational class, blood pressure, glycemic control
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7SAMMANFATTNING PÅ SVENSKA
Antalet människor som lever med diabetes ökar i världen. Framför allt ökar förekom-
sten av typ 2 diabetes som till stor del orsakas av övervikt, för lite fysisk aktivitet och 
andra livsstilsfaktorer. Att ha diabetes innebär en ökad risk för fl era hjärt-kärlsjukdo-
mar däribland stroke. 
Denna avhandling hade två övergripande mål. Det första var att undersöka om blod-
trycksläge i det högre normalområdet samt låg socioekonomisk position (defi nierad 
av yrke) hos män i 50-års åldern innebar en ökad risk för senare utveckling av typ 2 
diabetes. Dessa två studier gjordes på data från Primärpreventiva studien i Göteborg. 
Det andra huvudmålet för avhandlingen var att beräkna den ökade risken för stroke 
vid olika blodtrycksnivåer för personer med typ 2 diabetes och för personer med typ 1 
diabetes vid olika nivåer av medelblodsockret (metabol kontroll) jämfört med risken i 
normalbefolkningen. Data och deltagare med diabetes erhölls från Nationella Diabe-
tesregistret och köns- och åldersmatchade kontrollpersoner från normalbefolkningen 
erhölls från befolkningsregistret.
Männen i Primärpreventiva studien följdes från början på 70-talet och fram till och 
med 2011. Under den tiden registrerades en diabetesdiagnos hos 13% av de 7494 
männen. Studien visade att män med blodtryck inom det högre normalområdet när de 
var ca 50 år hade en ökad risk att senare insjukna i typ 2 diabetes, jämfört med män 
med lägre blodtryck. Dessutom hade män med manuella yrken en signifi kant ökad 
risk för diabetes jämfört med högre tjänstemän och motsvarande. En stor del av den 
ökade risken förklarades av de klassiska riskfaktorerna för diabetes som tex övervikt 
och låg fysisk aktivitet vilka var mer vanligt förekommande i de lägre socioekono-
miska klasserna men en oberoende riskökning kvarstod. 
Patienter med typ 2 diabetes hade en ökad risk för ischemisk stroke (blodpropp i hjär-
nans kärl) vid alla blodtrycksnivåer jämfört med kontroller ur befolkningen. Dock var 
risken för hemorrhagisk stroke (blödning i hjärnan) hos personer med typ 2 diabetes 
och blodtryck 120-139/70-89 mmHg lägre än för kontroller. Detta gjorde att personer 
med typ 2 diabetes och blodtryck under 130/80 mmHg hade en total risk för stroke 
som var jämförbar med den hos personer utan diabetes.
För patienter med typ 1 diabetes var risken för stroke ökad vid alla nivåer av metabol 
kontroll jämfört med risken i normalbefolkningen. Dock ökade risken kraftigt vid 
sämre metabol kontroll. Risken steg från 75% ökning av strokerisken bland de med 
bäst metabol kontroll till en åtta gånger ökad risk för stroke i gruppen med sämst me-
tabol kontroll jämfört med normalbefolkningen.
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ABBREVIATIONS
WHO  World Health Organization
ADA  American Diabetes Association
OGTT  oral glucose tolerance test 
IFG  impaired fasting glucose 
IGT  impaired glucose tolerance 
BMI  body mass index
SEP  socioeconomic position
SBP  systolic blood pressure
DBP  diastolic blood pressure
NDR  National Diabetes Register 
NPR  National Patient Register
CDR  Cause of Death Register
ICD   International Classifi cation of Diseases
LISA    Longitudinal Integration Database for Health Insurance and Labour 
Market Studies register
ESRD  end-stage renal disease
IFCC   International Federation of Clinical Chemistry and laboratory medi-
cine
NGSP  National Glycohemoglobin Standardization Program
AF  atrial fi brillation
HF  heart failure
CHD  coronary heart disease
AMI  acute myocardial infarction
HR  hazard ratio
CI  confi dence interval
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 INTRODUCTION
D iabetes is an important cause of morbidity and mortality worldwide by causing both micro- and macrovascular complications (1-3). The most common results of 
microvascular angiopathy are loss of renal function, blindness, and neuropathy while 
the macrovascular complications result in cardiovascular diseases such as ischemic 
heart disease and stroke (2). 
There are two main forms of diabetes - type 1 and type 2. Elevated blood glucose level 
is a common feature but the pathogenesis in the two forms is very different. Type 1 
diabetes is caused by an autoimmune destruction of the insulin-producing beta cells 
in the pancreas leading to insulin defi ciency, while the main feature of type 2 diabetes 
is insulin resistance. The vast majority of all diabetes worldwide is type 2 diabetes 
(>90%) and the prevalence has increased in the world in the last decades (4), mainly 
due to rapidly increasing overweight and obesity. Therefore, it is important to deter-
mine risk factors for diabetes in order to improve knowledge about what action should 
be taken to prevent diabetes type 2.  
Stroke is a vascular disorder affecting the vessels in the brain, frequently resulting in 
long-lasting neurological defi cits or death. According to the Global Burden of Dis-
ease study stroke was the second most common cause of death in the world and the 
third most common cause of disability-adjusted life-years in 2010 (3, 5). Patients with 
diabetes are more affected by stroke than persons without diabetes (6). Therefore it is 
important to determine what factors increase the risk of stroke in diabetes patients in 
order to protect them from this condition with potentially huge impact on everyday 
life.
Diagnosis of diabetes
Diabetes is diagnosed by clinical symptoms in the patients and by measuring the 
glucose levels in plasma. Current diagnostic criteria for diabetes defi ned by the World 
Health Organization (WHO) have been in use since 1998 when the cut-off limit for 
fasting plasma glucose was lowered (7, 8). Since 2010 both WHO and the American 
Diabetes Association (ADA) also recommend the use of HbA1c as a method of diag-
nosing diabetes (9, 10). For diagnosis criteria, see Table 1.
The oral glucose tolerance test (OGTT) is used for diagnosis when blood glucose 
levels are non-conclusive, during pregnancy or sometimes in epidemiology cohort 
studies. After overnight fasting, 75 g of glucose is ingested and plasma glucose values 
are measured after 2 hours (8). 
Individuals whose glucose levels do not meet criteria for diabetes, yet are higher than 
those considered to be normal, have been identifi ed as impaired fasting glucose (IFG) 
and/or impaired glucose tolerance (IGT). These individuals have been shown to be at 
an increased risk for cardiovascular disease and future diabetes (11, 12). 
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 IFG (Impaired 
Fasting Glucose) 
IGT (Impaired 
Glucose Tolerance) 
Diabetes 
Fasting  ?6.1- <7.0 <7.0 ?7.0* 
2 hour post-load OGTT <7.8 ?7.8 - <11.1 ?11.1* 
HbA1C (mmol/mol) Not applicable Not applicable ?48* 
Random glucose  Not applicable Not applicable ?11.1 
and classical 
symptoms 
Glucose values in venous plasma glucose mmol/l. *For the diagnosis of diabetes a pathological 
plasma glucose value must be confirmed in a repeat sample with the same analysis method if not 
HbA1c value tested simultaneously indicates diabetes and vice versa. 
Table 1. Diagnostic criteria for diabetes, IFG and IGT according to WHO (7)
Type 1 diabetes
Type 1 diabetes is an autoimmune disease leading to destruction of the insulin pro-
ducing β-cells in the pancreas. Patients with type 1 diabetes have an absolute insulin 
defi cit and require insulin treatment from the start. 
Type 1 diabetes constitutes 5-10% of the diabetes worldwide and approximately 10-
15% of the diabetes cases in Sweden (13, 14). The incidence and prevalence of type 
1 diabetes vary substantially in the world with high rates in for example the Nordic 
countries, Canada and Sardinia (Italy) while China and India have much lower inci-
dence and prevalence (15, 16). An increased incidence of type 1 diabetes has been 
seen in the last decades in particular in countries with historically high incidence. 
This increase has been most conspicuous  among younger children (15). The mecha-
nism underlying the difference in prevalence between countries and the increase in 
incidence rates during the last decades are unknown but are largely attributed to envi-
ronmental infl uences. 
Type 1 diabetes develops due to a combination of genetic predisposition and unknown 
environmental factors (16). Several loci on different chromosomes have been con-
nected to type 1 diabetes and if this genetic susceptibility is combined with envi-
ronmental factors the disease may appear. Environmental factors that have been dis-
cussed are dietary factors like substances in cows’ milk and N-nitroso compounds in 
meat, vitamin D and different viruses (15, 17). Another factor discussed is the “the 
hygiene hypothesis”. This hypothesis postulates that type 1 diabetes develops due to 
less microbial stimuli for the immune system in many developed societies (17). 
The clinical characteristics of the patient with newly diagnosed diabetes together with 
symptoms at onset, measurement of autoantibodies and level of C-peptide are often 
enough to distinguish type 1 diabetes from other forms of diabetes (18). The autoanti-
bodies are directed to different substances connected to the insulin producing β-cells. 
The C-peptide is formed when endogenous insulin is synthesized. 
The development over the last decades of insulin analogues, better devices for self-
monitoring of blood glucose, new mechanical technologies for insulin administration 
have improved treatment of type 1 diabetes. The goal for treatment of type 1 diabetes 
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patients is to maintain a blood glucose level which gives a minimum of symptoms of 
both high and low plasma glucose and to minimize secondary complications.  
Type 2 diabetes
Over 90% of the diabetes cases in the world are diabetes type 2 (19). The prevalence 
in the world has been rising the last decades due to population ageing and changes in 
lifestyle (4). Global age-standardized prevalence of type 2 diabetes increased from 
4.3% in 1980 to 9.0% in 2 014 for men and from 5.0% to 7.9% in women. The fastest 
increase in prevalence occurred in low- and middle-income countries (4). In Sweden, 
slightly surprisingly, no increase in incidence has been observed but there has been an 
increase in prevalence (20, 21), mostly due to increasing life expectancy overall and 
improved survival in patients with diabetes. The projection for the future is a further 
increase in prevalence of type 2 diabetes both in Sweden and in the rest of the world 
(19, 20).
Pathogenesis of type 2 diabetes
In a healthy individual without diabetes blood glucose level is maintained within a 
tight range through a feedback loop between insulin sensitive tissue (muscles, adipose 
tissue and liver) and the insulin producing β-cells in the pancreas. Insulin released 
from the β-cells stimulates the uptake of glucose, amino acids and fatty acids in insu-
lin-sensitive tissues. The insulin-sensitive tissues feed back information to the β-cells 
about their need for insulin by a so far unidentifi ed mediator (22). 
Type 2 diabetes develops as a consequence of chronic fuel excess resulting in insulin 
resistance and β-cell dysfunction (10). When insulin resistance occurs in the insulin-
sensitive tissue, as most often seen with obesity, the β-cells increase their insulin out-
put in order to override the insulin resistance and maintain normal glucose levels. 
When the β-cells no longer are capable of producing enough insulin to overcome the 
resistance in the tissue, the glucose levels start to rise. It is the magnitude of β-cell 
dysfunction that determines the degree of elevation in plasma glucose. Insulin resis-
tance is already well established when IGT is present and with declining β-cell func-
tion IGT progresses to type 2 diabetes. In recent years β-cell dysfunction has emerged 
as potentially the most important part in the pathophysiology of type 2 diabetes. In-
dividuals with susceptible β-cell function fail to adapt to overnutrition and go on to 
develop type 2 diabetes (10). 
Genes and environmental factors are both important in emerging insulin resistance 
and β-cell dysfunction. Since our gene pool will not have changed within a short time 
frame, environmental factors – lifestyle factors – are crucial in the emerging global 
type 2 diabetes epidemic (10, 22). 
Risk factors of type 2 diabetes
A wide range of conditions have been associated with an increased risk of developing 
type 2 diabetes. The risk factors of type 2 diabetes can be divided into modifi able and 
non-modifi able risk factors. Below is a selection of some predictors of type 2 diabetes. 
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Non-modifi able risk factors 
Several susceptible genetic loci have been associated with type 2 diabetes and the 
frequency of these loci alter between different ethnic groups (23). The prevalence of 
type 2 diabetes increases with age (20). Men develop type 2 diabetes at a lower BMI 
than women at the same age (24). In the last years interest has been directed towards 
the fetal intrauterine milieu. Adverse circumstances in the intrauterine milieu might 
lead to alterations in gene expression that are not associated with changes in DNA se-
quences (23). Low birth weight as well as high birth weight has been associated with 
a higher risk of developing type 2 diabetes later in life (25, 26). Gestational diabetes, a 
carbohydrate intolerance fi rst presenting in pregnancy, is a risk factor for development 
of type 2 diabetes later in life for the affl icted woman and exposure to intrauterine 
hyperglycemia increases the risk of type 2 diabetes later in life for the offspring (27). 
Modifi able risk factors 
Obesity is the strongest risk factor for type 2 diabetes (28) and visceral adiposity is 
of special importance (29). Physical activity can affect the risk of developing type 2 
diabetes by reducing weight and by decreasing insulin resistance (30). Dietary factors 
such as increasing the amount of vegetables, lower intake of meat, sweets, high-fat 
dairy and refi ned grains reduce the risk of type 2 diabetes (31). Lifestyle intervention 
programs with increased physical activity and diet changes reduce the risk of type 2 
diabetes (32, 33). Other modifi able risk factors shown to affect the risk of developing 
diabetes are psychological stress (34) and smoking (35). 
Hypertension and type 2 diabetes are two conditions well known to coexist and type 
2 diabetes patients have higher blood pressure than persons without diabetes (36). 
The reasons for this association are not fully established but disturbances in the mi-
crocirculation causing insulin resistance, subsequent hyperinsulinemia and impaired 
endothelial function could be pathophysiological mechanisms linking the two condi-
tions (37, 38). Studies have also shown that hypertension per se is a predictor of type 
2 diabetes (39, 40). Studies with a follow-up of up to 10 years have shown that blood 
pressure within the upper normal range is associated with increased risk of diabetes 
(41, 42). However, if high-normal blood pressure persists as a risk factor for subse-
quent development of diabetes after a prolonged follow-up is unknown. 
Socioeconomic position (SEP) refers to the social and economic factors that affect 
what position an individual or group of individuals hold in the society (43). It can be 
defi ned as a combined concept that includes both resource-based measures and pres-
tige-based measures. Different indicators of SEP can be used, for example education, 
occupation and income (43). SEP affects overall and cause-specifi c mortality (44) and 
risk factors for cardiovascular diseases have been shown to be unevenly distributed 
across SEP categories (45). SEP has also been identifi ed as a predictor for diabetes 
(46) at least in studies with a maximum of 15 years of follow-up. The difference in 
incidence of type 2 diabetes between different SEP groups is partly explained by dif-
ferences in prevalence of classical risk factors for type 2 diabetes like obesity, mental 
stress and low physical activity (47). If SEP defi ned by occupation among Swedish 
men is an independent predictor for type 2 diabetes at a longer follow-up, into older 
age, has not been extensively examined. 
17
Management of type 2 diabetes
While type 1 diabetes typically has a rapid onset with symptoms during some weeks 
before diagnosis, type 2 diabetes can be present for several years without much symp-
toms causing the patient to seek medical care. Type 1 diabetes patients have an abso-
lute insulin defi ciency and need insulin replacement therapy from start which type 2 
diabetes patients seldom do. Lifestyle modifi cation is nearly always needed for both 
types, but particularly in type 2 diabetes. Pharmacological therapies for managing 
hyperglycemia in type 2 diabetes can roughly be divided into one of three groups 
– insulin providers (insulin, sulphonylureas, meglitinides, glucagon-like peptide-1 
[GLP-1] receptor agonists, dipeptidylpeptidase-4 [DPP-4] inhibitors), insulin sensi-
tizers (metformin, pioglitazone) and glucose adsorption inhibitors (alpha-glucosidase 
inhibitors, sodium-glucose co-transporter-2 [SGLT2] inhibitors) (48). As for type 1 
diabetes patients, the goal with the treatment is to have a glucose level without symp-
toms in everyday life and to minimize secondary complications. 
Stroke
WHO defi nes stroke as an acute neurological defi cit caused by a focal injury of the 
central nervous system with symptoms lasting more than 24 hours or leading to death, 
with no apparent cause other than that of vascular origin (49). Stroke is classifi ed as 
ischemic or hemorrhagic based on the underlying pathology. For correct classifi cation 
neuroimaging with either computer tomography (CT) or magnetic resonance imaging 
(MRI) is required. 
Ischemic strokes appear when a blood vessel in the brain becomes partly or totally 
obstructed. This leads to lack of blood supply “down-stream” from the obstruction 
causing focal ischemia in the tissue and later cell necrosis in the affected area. Hem-
orrhagic stroke arises when a blood vessel ruptures and causes a bleeding. The blood 
distorts and compresses the cerebral tissue causing necrosis. Ischemic stroke repre-
sents the greater part of stroke subtypes, approximately 85% in high-income coun-
tries like Sweden, and thus the hemorrhagic strokes a lesser part, approximately 15%. 
However, in middle-and low-income countries hemorrhagic stroke represents a larger 
share of the stroke cases, up to approximately 25% (50).
Ischemic stroke can be classifi ed into different subtypes based on the underlying 
pathophysiological mechanism causing the obstruction in the vessel. According to the 
TOAST (Trial of Org. 10172 in Acute Stroke Treatment) classifi cation system these 
subtypes are: large vessel disease, small vessel disease, cardioembolic stroke, stroke 
of other determined etiology, undetermined stroke and cryptogenic stroke (51). Hem-
orrhagic stroke is subclassifi ed as either intracerebral hemorrhage or subarachnoid 
hemorrhage depending on the site and origin of the bleeding. 
Risk factors of stroke 
There are several well-known risk factors for stroke. Age is one important risk factor 
although a non-modifi able one. However, from the INTERSTROKE and other stud-
ies we also know that hypertension, smoking, waist-to-hip ratio, diet, regular physical 
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activity, diabetes, heavy alcohol intake, psychological stress and depression, cardiac 
causes (for example atrial fi brillation) and lipid profi le are risk factors for stroke. The 
INTERSTROKE study estimated that these ten modifi able risk factors accounted for 
approximately 90% of all strokes (52). 
Diabetes per se confers an increased risk of stroke compared to people without diabe-
tes. The fi gures differ between studies but having diabetes approximately doubles the 
risk of stroke (53, 54). While most studies have found an association between diabetes 
and ischemic stroke, there have been confl icting fi ndings concerning if diabetes is a 
risk factor for hemorrhagic stroke or not. Some studies have found an association be-
tween diabetes and hemorrhagic stroke (55, 56) while others have not (57, 58). 
Above all, diabetes seems to be an important risk factor for stroke in younger ages 
and for women (54). Risk factors for stroke like hypertension and atrial fi brillation are 
more prevalent in people with compared to people without diabetes (54, 59). 
Stroke in patients with diabetes
Risk factors of stroke in patients with type 1 diabetes
Several of the risk factors of stroke in people without diabetes are also risk factors in 
people with type 1 diabetes. Studies have shown that higher age, longer diabetes dura-
tion, hypertension, diabetic nephropathy, history of smoking, level of glycemic con-
trol and cholesterol levels affect the risk of stroke in type 1 diabetes patients (60, 61)
Glycemic control and risk of stroke
In the last decade, an increasing number of studies have shown that HbA1c level 
affects the risk of cardiovascular disease in type 1 diabetes patients (60, 62). How-
ever, the number of stroke in these studies has often been limited (61-63). The often 
cited Diabetes Control and Complication Trial (DCCT) where they found that lower 
HbA1c gave less cardiovascular events only had 6 cases of stroke (62). There is no 
large study on patients with type 1 diabetes with suffi cient number of strokes that has 
estimated the excess risk of stroke in patients with type 1 diabetes compared to the 
general population.
Risk factors of stroke in patients with type 2 diabetes
The risk factors of stroke are virtually the same for people without diabetes as for 
people with type 2 diabetes. The hyperglycemic state is specifi c for people with diabe-
tes and high HbA1c has been shown to be a risk factor of ischemic stroke (64). How-
ever, studies comparing intensive versus standard glucose control in type 2 diabetes 
patients have so far failed to show a reduced risk of stroke (65).
Blood pressure and risk of stroke
Blood pressure is a well-known risk factor for cardiovascular disease in type 2 diabe-
tes patients (36). There has been an intensive debate how to interpret studies and what 
blood pressure target should be aimed for among patients with type 2 diabetes. In the 
beginning of the third millennium guidelines advocated a blood pressure treatment 
target of <130/80 mmHg for patients with type 2 diabetes based on fi ndings in stud-
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ies such as HOT (66), HOPE (67) and UKPDS (68). However, the evidence for ben-
efi ts concerning cardiovascular outcomes when treating the blood pressure below 130 
mmHg has been found to be weak. Additional, studies have indicated a J-shaped curve 
between achieved blood pressure and cardiovascular out-come (69). Therefore, recent 
European guidelines have advocated a more conservative view, aiming for a blood 
pressure goal of <140/85 mmHg and individualized goals for blood pressure targets 
taking in account age, duration of diabetes and co-morbidities (48). The subject is still 
highly controversial and several studies comparing patients with type 2 diabetes with 
different blood pressure levels have tried to determine what blood pressure should be 
aimed at when treating patients with type 2 diabetes (70, 71). However, studies esti-
mating the excess risk of stroke for type 2 diabetes patients at several different blood 
pressure levels compared to the risk of the general population do not exist. 
Management of stroke and stroke out comes in diabetes patients
Hyperglycemia often occurs in the acute phase of a stroke due to activation of the hy-
pothalamic-pituitary-adrenal axis leading to raised amounts of glucocorticoids (65). 
This hyperglycemia can be seen both in patients with and without previous known 
diabetes. The hyperglycemia can be caused by pre-existing glucosintolerance or un-
detected diabetes but can also be the result of a stress respons. Hyperglycemia at 
admission for ischemic stroke has been shown to be associated with increased 30-day 
mortality and poor functional outcome in patients without previous diabetes (72). 
However, studies have failed to prove that glucose-lowering treatment improves clini-
cal outcome in patients with acute ischemic stroke. In experimental studies hypergly-
cemia has been linked to several mechanisms which could increase brain damage in 
ischemic stroke, for example, reperfusion injury and impaired recanalization (65). 
Taken together, guidelines advocate treatment of glucose levels >10 mmol/L in the 
acute phase of an ischemic stroke (73) and monitoring of the risk of hypoglycemia. 
Studies have shown that the distribution of subtypes of stroke differ between people 
with and without diabetes. People with diabetes have a larger proportion of lacunar 
infarcts (59), more subcortical infarcts and lower relative incidence of intracerebral 
haemorrhage (74) compared to people without diabetes. Stroke severity does not seem 
to differ between patients with or without diabetes (75).
The mortality rates during the fi rst 3 months after an ischemic stroke do not differ 
between patients with diabetes compared to patients without diabetes, while mortality 
rates in one-year survivors after a stroke is increased among patients with compared 
to patients without diabetes (65). The risk of recurrent stroke is increased in patients 
with type 1 and type 2 diabetes compared to patients without diabetes (75).   
In the present series of studies we used data from several sources, including popu-
lation cohort studies with long-term follow up as well as the very large NDR with 
detailed data on patients with diabetes in combination with data from other registers. 
Type 2 diabetes often develops later in life and with the world’s aging population it 
is becoming increasingly important to know to which extent the effect of risk factors 
persists into older ages. We wanted to ascertain if high-normal blood pressure and 
occupational class among middle aged men in Gothenburg persisted as predictors of 
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type 2 diabetes even after an extended follow-up, something that to our knowledge 
has not been examined.  We also estimated the excess risk of stroke compared to the 
general population at several different blood pressure levels for patients with type 2 
diabetes and at different HbA1c levels for patients with type 1 diabetes in uniquely 
large cohorts. Similar estimates of excess risk at different risk factor levels have not 
been assessed before. Excess risk of stroke for patients with diabetes is important 
information, for example to decision makers when deciding how to allocate resources 
from the common health care budget to risk factor control in patients with diabetes. 
21
AIMS
There were two overall aims of this thesis. The fi rst was to evaluate potential predic-
tors of type 2 diabetes in middle aged men. The second aim was to estimate the excess 
risk of stroke in patients with type 1 and 2 diabetes compared to the general popula-
tion by specifi c characteristics as detailed below.
Specifi c aims
Paper I         To evaluate if high-normal blood pressure in middle-aged men predicts 
development of type 2 diabetes during an extended follow-up over 35 
years.
Paper II        To assess if low occupational class is an independent predictor of type 2 
diabetes in Swedish men, after adjustment for conventional risk factors 
and psychological stress.
Paper III       To estimate the excess risk of stroke for type 2 diabetes patients at differ-
ent blood pressure levels compared to the general population.
Paper IV       To estimate the excess risk of stroke in type 1 diabetes patients with dif-
ferent glycemic control compared to the general population
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PATIENTS AND METHODS
Paper I and II of this thesis are based on the Multifactor Primary Prevention study. 
Paper III and IV, are based on cohorts of patients with diabetes derived from the 
National Diabetes Register (NDR) and sex, age and county matched control cohorts 
from the general population. All studies were approved by the regional ethical board 
of Gothenburg.
Study populations  
The Multifactor Primary Prevention study (Paper I and II)
The Multifactor Primary Prevention study was launched in 1970 in order to explore 
if directed intervention against high levels of three predefi ned cardiovascular risk fac-
tors, hypertension, smoking and hypercholesterolemia, had any effect on cardiovascu-
lar outcomes (76, 77). The study included all men in the city born between 1915 and 
1925 (except those born 1923 because these were eligible for participation in another 
cohort study). The men were 47 to 55 years of age (mean age about 51 years) at study 
start. The men were divided into three groups of approximately 10 000 men in each 
group, where one group was chosen as the intervention group and the two others as 
control groups. All men in the intervention group were sent a postal questionnaire. 
Those who responded to the questionnaire were invited to a physical examination 
where risk factors were identifi ed and intervention started if required. The intervention 
criteria were antihypertensive treatment if systolic blood pressure was >175 mmHg or 
if diastolic blood pressure was >115 mmHg, dietary advice if serum cholesterol levels 
were >260 mg per 100 ml (>6.8 mmol/1), and referral to anti-smoking clinics for par-
ticipants who smoked ≥15 cigarettes per day. Of the 10 000 men in the intervention 
group 7494 (75%) attended the basal physical examination. A small subsample (2%) 
of men in one of the control groups were sent the questionnaire and invited to physi-
cal examination in order to check comparability between the intervention and control 
groups (76). No action on risk factors was taken in the control group. 
A fi rst follow-up was done after 4 years where the whole intervention group was 
invited for a re-examination and effects of the intervention on risk factors were mea-
sured. A random subsample of 11% in one of the control groups were also invited to 
re-examination. Ten years after entry, a random sample of 20% of the intervention 
group and a random sample of 20% in one of the control groups were invited for a 
fi nal examination. 
Cardiovascular end-points and cause-specifi c mortality were registered for partici-
pants in all three groups (both the intervention group and the two controls groups). 
The end-points were collected from assembling all death certifi cates in the city and by 
matching against the computerized Cause-of-death register, the Gothenburg Myocar-
dial Infarction register and Stroke register (76).  
At the fi nal follow-up in 1983 it was found that the risk factors levels had markedly 
decreased in the intervention group – but also in the control group. No difference was 
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found between intervention group and control group concerning total mortality, stroke 
and cardiovascular disease incidence. Except for having taken part in an intervention 
study, the thoroughly examined intervention group of 7494 men can therefore be re-
garded as representative of the middle aged male general population in Gothenburg in 
the beginning of the seventies. 
Paper I
For the purpose of this paper we used data from the 7494 men in the intervention 
group of the Multifactor Primary Prevention study. We excluded 149 patients who re-
ported known diabetes at the baseline examination. We also excluded 14 participants 
with missing information on blood pressure data.
Paper II
From the 7494 men in the intervention group of the Multifactor Primary Prevention 
study we excluded 238 men that reported preexisting diabetes, stroke or myocardial 
infarction. We also excluded 382 men that could not be classifi ed according to Swed-
ish socio-economic classifi cation system. 
Patients from the National Diabetes Register and matched controls (Paper 
III and IV)
The Swedish National Diabetes Register (NDR) was started in 1996 as a quality as-
surance tool in diabetes care. The purpose was to monitor the results from health care 
centers from year to year, compare the results with regional and national means and 
feed-back the information to the reporting health care center for quality improve-
ment work (78). The health care centers report to the NDR, annually, basal clinical 
characteristics of the patients as well as measurements of risk factors and presence 
of complications of diabetes. The number of patients with diabetes reported to NDR 
have increased through the years. Type 1 diabetes patients are mainly taken care of 
at hospital based out-patients clinics and these started to report to NDR at an earlier 
stage compared to most primary care clinics where type 2 diabetes patients often are 
managed. Therefore, the coverage among type 1 diabetes patients was estimated to be 
50% already in 2003, while the coverage increased more slowly for type 2 diabetes 
patients. In the annual report from NDR 2013 it was estimated that 88% of all patients 
with known diabetes in Sweden were reported to the NDR. 
Paper III
In the NDR, type 2 diabetes is defi ned as diabetes treated with diet only, oral hypogly-
cemic agents only or insulin only or in combination with oral hypoglycemic agents if 
onset of diabetes ≥40 years (79).
For the purpose of Paper III, we included all type 2 diabetes patients with at least one 
registration in the NDR between 1998 and 2011. For every type 2 diabetes patient, 5 
age-, sex-, and county-matched controls were included from the Swedish Total Popu-
lation Registry held by Statistics Sweden (Statistiska centralbyrån). This procedure 
rendered us 435,660 people with type 2 diabetes and 2,144,567 controls from the gen-
eral population. We excluded controls that had a registration in the NDR (394), type 2 
diabetes patients and controls who died before the start of the study (26,981), and type 
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2 diabetes patients and controls with a diagnosis of stroke registered before the start 
of the study (231,269). After these exclusions, 408,076 people with and 1,913,507 
without type 2 diabetes remained for analysis.
Paper IV
Type 1 diabetes is defi ned in the NDR as treatment with insulin and a diagnosis at ≤30 
years of age. This defi nition has been validated in the register and was found to be 
accurate in 97% of the cases listed (80). 
In this study, 33,965 type 1 diabetes patients with at least one registration in the NDR 
from January 1 1998 until December 31 2011 were included. We randomly selected 
fi ve controls matched for age, sex, and county of residence for each type 1 diabetes 
patient from the Swedish Total Population Registry. Excluded from the study were 
controls who had a registration in the NDR (6967) and type 1 diabetes patients and 
controls with a diagnosis of stroke which were registered before starting the study 
(506 and 2715, respectively). Excluded were also type 1 diabetes patients and controls 
that died before starting the study (3 and 205, respectively), usually controls who died 
between the date when the random selection of controls was made and the date when 
the index case was registered in the NDR. We also excluded type 1 diabetes patients 
and their controls with missing vital status data in the NDR (3 and 14, respectively). 
After these exclusions, 33,453 type 1 diabetes patients and 159,924 controls remained 
for analysis.
Methods
Registers 
Administrative health care registers detailed below are used in all four papers either 
for gathering data to the studies and/or collecting end-points. 
The Swedish National Patient Register (Paper I-IV)
The Swedish National Patient Register (NPR), previously named the Swedish hos-
pital discharge register, is an administrative health care register where all discharges 
from hospital in Sweden are registered with primary and contributing diagnoses. The 
diagnoses are coded according to the International Classifi cation of Disease (ICD). 
The NPR has operated on a nationwide basis since 1987, but all discharges from 
Gothenburg hospitals have been entered in the national register since 1970 (except 
in 1976 owing to a legislative change for that year). The accuracy of the discharge 
diagnoses, and the positive predictive value, differ between different diagnoses, but 
is generally 85-95% for major cardiovascular categories (81). For stroke diagnoses, a 
study in 2004 showed a sensitivity for stroke diagnosis of 92% when combined with 
the Cause of death register (82). 
The Cause of Death Register (Paper I-IV)
The Cause of Death Register (CRD) is another administrative health care register also 
held by the National Board of Health and Welfare in Sweden. All deaths in Sweden 
are mandatory to register in CDR with an ICD code for cause of death. The CRD 
holds information about cause of deaths since 1961. 
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The Longitudinal Integration Database for Health Insurance and Labour Market 
Studies register (Paper III and IV)    
The Longitudinal Integration Database for Health Insurance and Labour Market Stud-
ies register (LISA) is an administrative register held by Statistics Sweden. This regis-
ter contains information about all citizens resident in Sweden and above 16 years of 
age. For the purpose of our studies, information about place of birth and educational 
level were retrieved from the LISA register.
The Multifactor Primary Prevention study (Paper I and II)
Data collection
Information collected from the questionnaire included self-reported previous health 
problems, including hypertension, smoking habits, physical activity, anti-hyperten-
sive treatment, self-perceived psychological stress and occupation. Previous health 
problems were assessed by questions like “Has a physician ever told you that you 
have diabetes?” or “Have you ever had myocardial infarction/bleeding of the brain/
thrombosis of the brain?” and considered existing if the participant answered “yes”. 
Smoking status was defi ned as non-smoker, former smoker of >1 month’s duration 
and current smoker. Physical activity during leisure time was divided into seden-
tary, moderate and regular exercise. Anti-hypertensive treatment was considered to 
be present if the participant answered “yes” to this question. Self-perceived psycho-
logical stress was assessed by a single question in the questionnaire defi ning stress as 
feeling tense, irritable, fi lled with anxiety or having sleeping diffi culties as a result of 
conditions at work or at home. The alternative responses were on a six-point scale as 
follows: 1: never experienced stress; 2: some period of stress ever; 3: some period of 
stress in the past 5 years; 4: several periods of stress in the past 5 years; 5: permanent 
stress in the past year; and 6: permanent stress over the past 5 years. Occupational 
classes were coded according to the Swedish socio-economic classifi cation system 
(83) (see next page). 
The baseline examination took place 1970 and 1973 in the afternoon. Weight was 
measured to the nearest 0.1 kg and height to the nearest 0.01 m. Body mass index 
(BMI) (weight in kg divided by measured height in m2) was categorized as <25 (nor-
mal), 25–30 (overweight) and >30 kg/m2 (obese). Serum cholesterol concentration 
was determined according to standard laboratory procedures.
Blood pressure was taken in the right arm with the participant seated, after a 4–5 
minute rest. A mercury manometer was used and measured to the nearest 2 mmHg. 
At the time for the study, the investigators noticed that a large proportion of the par-
ticipants had high blood pressure. Therefore, a random subsample of the participants 
examined in the beginning of the study (84 out of the 2180 fi rst examined) were re-
examined concerning the blood pressure two weeks after the fi rst examination. Mean 
systolic blood pressure (SBP) and diastolic blood pressure (DBP) were then lower in 
comparison to the values recorded during the screening examination, mean SBP was 
7.6 mmHg lower and mean DBP 8.9 mmHg lower. For participants with the highest 
blood pressure levels during the screening, the mean SBP and DBP was even lower 
two weeks later; 16.1 mmHg and 18.0 mmHg lower respectively.
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Blood pressure categories
According to their blood pressure, all participants were divided into one predefi ned 
systolic and diastolic blood pressure category based on World Health Organization-
International Society of Hypertension (WHO-ISH) defi nitions (84). The SBP cate-
gories were: <130 (normal), 130–139 (high-normal), 140–159 (mild hypertension) 
and ≥160 (moderate and severe hypertension) mmHg. The DBP categories were: <85 
(normal), 85–89 (high-normal), and ≥90 (hypertension) mmHg. 
Occupational classes
Based on information from the questionnaire the participants were classifi ed into the 
following fi ve occupational classes and coded according to the Swedish socio-eco-
nomic classifi cation system (83): (1) unskilled and semi-skilled workers; (2) skilled 
workers; (3) foremen in industrial production and assistant non-manual employees; 
(4) intermediate non-manual employees; and (5) employed and self-employed profes-
sionals, higher civil servants and executives. 
Ascertainment of diabetes in Paper I and II
Using the personal identifi cation number (PIN), unique for every citizen in Sweden, 
the participants were followed from the date of their baseline examination until 31 
December 2008. Cases of diabetes were identifi ed by NPR and the CRD either as 
principal or secondary diagnosis of diabetes. The following ICD codes were used to 
identify cases of diabetes; 250 (ICD-8), 250 (ICD-9), or E10–E14 (ICD-10).
Patients from the National Diabetes Register and matched controls (Paper 
III and IV)
Data collection
By using the PIN, information concerning co-morbidities, place of birth and educa-
tional level was linked from the NPR and LISA registers, respectively, for participants 
with and without diabetes. 
Place of birth was categorized as in Sweden or elsewhere, education was categorized 
as low (compulsory only), intermediate, and high (university or similar). 
In order to exclude participants (with and without diabetes) with a prior stroke before 
the start of the study, the following codes were used: hemorrhagic stroke 431, 432X 
(ICD-9), I61, I62.9 (ICD-10); ischemic stroke 433, 434, 436, 437X (ICD-9), I63, I64, 
I67.9 (ICD-10).
In order to identify co-morbidities following ICD codes were used; acute myocardial 
infarction (AMI) 410 (ICD-9), I21 (ICD-10); coronary heart disease (CHD) 410–
414 (ICD-9), I20–I25 (ICD-10); atrial fi brillation (AF) 427D (ICD-9), I48 (ICD-10); 
valve disease 394–397, 424 (ICD-9), I05-I09, I34-I36 (ICD-10); heart failure (HF) 
428 (ICD-9), I50 (ICD-10); and cancer 140–208 (ICD-9), C00–C97 (ICD-10).
For the patients with diabetes, data on lifestyle, risk factors such as blood pressure 
and cholesterol levels, and complications of diabetes were retrieved from the NDR. 
No similar data was available for the controls. All data in the NDR is collected by 
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physicians and nurses at hospitals and health care centers in Sweden reporting to the 
register. 
The standard for blood pressure measurement used in the NDR is the mean value 
(mmHg) of two readings in the supine position using a cuff of appropriate size and af-
ter at least 5 minutes of rest. Smoking was coded as present in active smokers and an-
tihypertensive treatment as present or not. Analyses of microalbuminuria and HbA1c 
were performed at the local laboratory. All health care laboratory units in Sweden 
are regularly validated by a quality assessment organization. Renal impairment was 
categorized as normoalbuminuria, microalbuminuria, macroalbuminuria, or stage 5 
chronic kidney disease (CKD). Microalbuminuria was defi ned as two out of three 
urine samples obtained within 1 year with either an albumin:creatinine ratio of 3–30 
mg/mmol (approximately 30–300 mg/g) or a urinary albumin clearance of 20–200 
μg/min (20–300 mg/L). Urinary albumin excretion was defi ned as macroalbuminuria 
if the albumin:creatinine ratio was >30 mg/mmol (close to ≥300 mg/g) or a urinary 
albumin clearance >200 μg/min (>300 mg/L). Stage 5 CKD (also called End-Stage 
Renal Disease, ESRD) was defi ned as an estimated glomerular fi ltration rate of <15 
ml/min or the need for renal dialysis or renal transplantation. Health care units in 
Sweden previously used the HbA1c method calibrated to the high performance liquid 
chromatography mono-S method. In September 2010, there was a national change to 
the calibration recommended by the International Federation of Clinical Chemistry 
and Laboratory Medicine (IFCC) and the National Glycohemoglobin Standardiza-
tion Program (NGSP). HbA1C values were converted according to the NGSP and are 
reported in percentages and in mmol/mol 
Blood pressure categories
To estimate the risk of stroke for patients with type 2 diabetes at different blood pres-
sure levels compared to the controls from the general population, the patients with 
diabetes were assigned to one of the following predefi ned blood pressure catego-
ries; <110/<65, 110-119/65-69, 120-129/70-79, 130-139/80-89, 140-159/90-99, and 
≥160/≥100 mmHg. Participants with discordant systolic and diastolic blood pressure 
were classifi ed into the higher category.
HbA1c categories
For the purpose of Paper IV, patients with type 1 diabetes were divided according to 
their HbA1c into one of the following categories in order to estimate the risk of stroke 
at different HbA1c levels compared to the general population (NGSP% / IFCC mmol/
mol) ; ≤6.9% (≤52 mmol/mol) 7.0–7.8% (53–62 mmol/mol) 7.9–8.7% (63–72 mmol/
mol) 8.8–9.6% (73–82 mmol/mol) ≥9.7% (≥83 mmol/mol).
Ascertainment of stroke in Paper III and IV
In both Paper III and IV patients with diabetes and controls from the general popula-
tion were followed from inclusion in the study to admission to hospital with a prin-
cipal diagnosis of stroke, to death, or to 31st of December 2011, whichever event oc-
curred fi rst. Following ICD-10 codes as primary diagnosis in NPR or CDR were used 
to identify stroke end-points; any stroke (I61, I62.9, I63, I64, I67.9), ischemic stroke 
(I63, I64, I67.9), and hemorrhagic stroke (I61, I62.9). 
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Statistical analyses
All papers in this thesis are observational prospective cohort studies. 
Descriptive statistics (Paper I-IV)
Descriptive statistics are presented as frequencies and percentages for categorical 
variables and in terms of means with standard deviations for continuous variables. 
In Paper I and II differences in the distribution of baseline characterises across the 
blood pressure and occupational classes were analysed by Chi-square trend test (Co-
chran-Armitage trend test) for categorical variables and by Spearman correlation test 
(Paper I) and the ANOVA linear trend test (Paper II) for continuous variables. In Pa-
per III and IV no such signifi cance testing were done in the baseline tables since this 
practice has been more and more abandoned and is now considered unnecessary and 
superfl uous (85).
All p-values are 2-sided and values <0.05 are considered statistically signifi cant.
Paper I 
Follow-up time in the study was from the baseline examination (January 1970 to 
March 1973) to a fi rst hospitalization with a diagnosis of diabetes (principal or sec-
ondary diagnosis), to death or to end of follow-up (31 December 2008). We calculated 
age-adjusted diabetes incidence rate per 100,000 person years for each blood pressure 
category. 
The hazard for developing diabetes in the different blood pressure categories were 
analyzed through proportional hazard regression (Cox regression) models where the 
lowest blood pressure category was used as reference. Three regression models were 
constructed with different sets of covariates. The multiple adjusted model was ad-
justed for age, BMI, cholesterol level, antihypertensive treatment, smoking, physi-
cal activity and occupational class. In an attempt to take the possibility of residual 
confounding into account we performed stratifi ed analyses across different BMI and 
smoking categories. Estimates from the proportional hazard regression models are 
presented as hazard ratios (HR) and 95% confi dence intervals (95% CI). The assump-
tion of proportional hazard was tested and holds for all our models.
A large proportion of the men (75%) had died at the end of the study due to the long 
follow-up and age at study entry. Therefore a fi gure with cumulative risk for diabetes 
within each blood pressure category where risk of death from other causes than diabe-
tes has been accounted for is presented (competing risk methodology). 
All analyses were performed using SAS software version 9.2 (SAS institute, Cary, 
NC, USA) and Statistical package R2.15 version.
Paper II
Follow-up time was as in Paper I. Age-adjusted diabetes incidence rates per 100,000 
person years for each occupational class were calculated as in Paper I.
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To even further take into account the long follow-up and the fact that a consider-
able proportion of the participants died during the study, competing risk regression 
was used to analyze and compare the hazards of developing diabetes in the different 
occupational classes. The highest occupational class (high offi cials) was used as a 
reference. To account for the non-proportionality in some variables, these were time-
averaged according to Schemper et al (86). Three regression models with different 
sets of covariates were constructed. The multiple adjusted model were adjusted for 
age, BMI, hypertension, smoking, physical activity and psychological stress. For 395 
participants there were missing data on psychological stress. For these men we cre-
ated a dummy variable which was entered into the model. Subdistribution hazard 
ratios (SHRs) and associated 95% CIs for diabetes are presented. 
One fi gure presents the cumulative incidence of diabetes and death across the occu-
pational classes and another fi gure presents the conditional probability of diabetes by 
occupational class.
All statistical analyses were performed using SAS software version 9.3 (SAS insti-
tute, Cary, NC, USA) and Statistical package R version 3.00.
Paper III and IV
Unadjusted incidence rates for stroke end-points were estimated and presented as 
events per 1000 person-years of follow-up with 95% confi dence intervals. Confi dence 
intervals for event rates are based on Poisson distribution. In Paper III incidence rate 
ratios with associated confi dence interval are also presented.
Cox regression models were constructed to study the relationship between diabetes 
patients with different updated mean blood pressure (Paper III) or HbA1c (Paper IV) 
and controls (reference). Updated mean blood pressure/HbA1c was defi ned as the 
mean value of all preceding measures and updated for each new measurement (e.g. 
when the third measurement from baseline was performed, the updated mean blood 
pressure/HbA1c was the mean of the three fi rst measurements). In the fi rst unad-
justed model the matching was taken into account by stratifying the Cox analysis on 
matched set of individuals. In the adjusted models, age and sex were entered as co-
variates along with the other covariates adjusted for and the patients with diabetes in 
each blood pressure/HbA1c category were compared to all controls grouped together. 
Diabetes duration was added as a stratifi cation variable in the Cox regression models, 
the controls were assigned to the same stratifi cation category as the patients in the 
diabetes group with whom they were matched. Subgroup analysis by sex, age and 
presence of previous cardiovascular disease in Paper III and by sex, diabetes duration 
category and renal impairment in Paper IV were performed. The subgroup analyses 
are presented by hazard ratios as well as forest plots. 
We also constructed Cox regression models to estimate the risk of stroke at different 
blood pressure/HbA1c categories within the groups of patients with diabetes. Type 2 
diabetes patients with an updated blood pressure of 120-129/70-79 mmHg were used 
as a reference in Paper III and type 1 diabetes patients with an updated HbA1c level 
of ≤6.9% (≤52 mmol/mol) were used as reference in Paper IV. In these models we 
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could adjust the analyses for several variables available in NDR since these data also 
were available in the control group in these analyses. The variables were entered as 
time-updated or time-updated mean variables i.e. when new information is registered 
in the NDR, the variables is updated. 
Hazard ratios (HRs) and associated 95% confi dence intervals (CIs) for stroke were 
estimated in all Cox regression models. The assumption of the proportional hazard 
was tested for all Cox regression analyses and was found to hold. All analyses were 
performed using SAS software version 9.3 in Paper III and SAS software version 9.4 
in Paper IV.
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RESULTS
High-normal blood pressure and long-term risk of type 2 diabetes: 35-
year prospective population based cohort study of men (Paper I)
The aim of this study was to evaluate if high-normal blood pressure in men at mid-life 
predicted later development of diabetes after an extended follow-up of 35 years. 
Baseline characteristics for participants in the different SBP groups are presented in 
Table 2. Participants in the higher SBP groups were slightly older, had higher BMI 
and cholesterol levels, were more likely to use antihypertensive medication, and at the 
same time less likely to be physically active, a current smoker or having a non-manual 
occupation.
 
 
Characteristics 
 
 
All 
N=7 333 
Systolic blood pressure categories 
 
<130 mm Hg 
(n=1278) 
 
130-139 mm Hg 
(n=1315) 
 
140-159 mm Hg
(n=2623) 
 
?160 mm Hg 
(n=2117) 
 
p-
values* 
Age, years, mean (SD) 51.6 (2.3) 51.2 (2.3) 51.3 (2.4) 51.6  (2.3) 51.9 (2.1) <0.0001  
Body Mass Index kg/m², mean (SD) 25.5 (3.2) 24.4 (2.9) 25.2 (2.9) 25.6 (3.2) 26.3  (3.5) <0.0001 
Obesity. BMI ?30, % (n)  8.1 (597) 3.4 (43) 5.6 (73) 8.2 (214) 12.6 (267) <0.0001 
Diastolic blood pressure, mm Hg, mean (SD) 95  (13)  82 (8) 88 (8) 94 (8) 107 (12) <0.0001 
Hypertension treatment, % (n) 5.4 (396) 0.7 (9) 0.7 (9) 3.2 (85) 13.8 (293) <0.0001 
Serum cholesterol mmol/L, mean (SD) 6.46 (1.15) 6.22 (1.08) 6.47 (1.10) 6.47 (1.17) 6.61 (1.18) <0.0001 
Never smokers, % (n) 29.5 (2152) 27.2 (347) 27.1 (355) 29.7 (775) 32.0 (675 0.0004 
Former smokers, % (n) 20.4 (1493) 19.0 (242) 20.9 (273) 21.3 (555) 20.0 (423) 0.68 
Current smokers, % (n) 50.1 (3660) 53.8  (686) 52.0 (681) 49.0 (1279) 48.0 (1014) 0.0004 
Physically active, % (n)  16.0  (1156) 18.3  (232) 17.6  (228) 16.1 (414) 13.5 (282) <0.0001 
Non-manual occupation, % (n) 27.9  (2044) 31.2 (399) 29.4 (386) 27.8 (728) 25.1 (531) <0.0001 
SD= standard deviation. BMI=Body Mass Index. *P-values calculated by chi-square trend test for categorical variables and by Spearman correlation test for 
continuous variables. 
Table 2. Baseline characteristics according to systolic blood pressure categories
After 35 years of follow-up (mean follow-up 28 years), 956 out of 7333 (13%) partici-
pants had received a diagnosis of diabetes in the NPR or CDR. The crude incidence of 
diabetes was 509 per 100,000 person years.
The risk of developing diabetes increased by higher SBP and DBP level as can be seen 
in Table 3. BMI had a major attenuating effect on the risk of developing diabetes, but 
even after adjustment for BMI and other covariates, the risk to develop diabetes was 
signifi cant higher for men with high-normal SBP (130-139 mmHg) at baseline com-
pared to men with SBP <130 mmHg (HR 1.43 95% [1.12-1.84]). 
The risk of developing diabetes during 35 years of follow-up, given death did not 
occur, was  19%, 30%, 31% and 49% if SBP at baseline was <130 mmHg, 130-139 
mmHg, 140-159 mmHg and >160 mmHg, respectively (Figure 1).  
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Blood pressure 
categories/treatment 
Number  
at risk 
Diabetes 
cases 
Diabetes
cases
per 100 000 
person years 
Age adjusted 
hazard ratios 
(95% CI) 
Age and BMI 
adjusted
hazard ratios 
(95% CI) 
Age and multivariable 
adjusted* hazard 
ratios
(95% CI) 
Systolic blood  pressure       
<130 mm Hg  
(normal) 
1 279 109 300 ref. ref. ref. 
130–139 mm Hg 
(high-normal) 
1 315 159 447 1.56  
(1.22-1.99) 
1.39 
(1.09-1.78) 
1.43 
 (1.12-1.84) 
140–159 mm Hg 
(mild hypertension) 
2622 330 472 1.66 
(1.34-2.07) 
1.40 
(1.13-1.75) 
1.43  
(1.14-1.79) 
?160 mm Hg 
(moderate/severe ) 
2117 358 693 2.68 
(2.16-3.32) 
2.03 
(1.63-2.52) 
1.95 
(1.55-2.46) 
Increase per  
10 mm Hg 
   1.16 
(1.13-1.18) 
1.12 
(1.08-1.14) 
1.10 
(1.07-1.14) 
Diastolic blood pressure       
<85 mm Hg  
(normal) 
1628 157 345 ref. ref. ref. 
85–89 mm Hg 
(high normal) 
896 83 343 1.02 
(0.78-1.33) 
0.95 
(0.72-1.23) 
0.93 
(0.70-1.22) 
?90 mm Hg 
(hypertension) 
4809 716 579 1.82 
(1.53-2.16) 
1.41 
(1.18-1.68) 
1.34 
(1.12-1.62) 
Increase per  
5 mm Hg 
   1.14 
(1.12-1.17) 
1.09 
(1.06-1.11) 
1.08 
(1.06-1.11) 
*Multivariable adjusted model included age, body mass index, cholesterol level, antihypertensive treatment, smoking, physical activity and 
occupational class.  
Table 3. Hazard ratios for diabetes incidence by blood pressure categories
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Figure 1. Conditional probability of diabetes according to different SBP 
classes, taking death attributable to other causes into account.
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Incidence of type 2 diabetes among occupational classes in Sweden: a 
35-year follow-up cohort study in middle-aged men (PaperII)
In this study we estimated the risk of developing diabetes in different occupational 
classes at mid-life. We evaluated to what extent any potential differences could be 
explained by conventional risk factors for diabetes and by psychological stress and if 
the differences persisted into older ages. 
The classical risk factors for diabetes were more prevalent in the lower occupational 
classes i.e. slightly higher mean BMI, and obesity rates, higher mean blood pressure, 
rates of smoking and a more sedentary lifestyle. The men in the lower occupational 
classes also reported more permanent stress than men in higher occupational classes 
(Table 4). 
Characteristics All
(n=6874)
High officials, 
professionals 
(n=793)
Intermediate, 
non-manual 
employees 
(n=1231) 
Assistant  
non-manual 
employees 
(n=1348) 
Skilled
workers 
(n=1871) 
Unskilled and 
semiskilled 
workers 
(n=1631)
P-value 
        
Age, years, mean (SD) 51.6 (2.3) 51.6 (2.3) 51.5 (2.3) 51.5 (2.2) 51.7 (2.2) 51.5 (2.3) 0.40 
BMI kg/m², mean (SD) 25.5 (3.2) 25.3 (3.0) 25.4 (3.1) 25.4 (3.1) 25.6 (3.1) 25.7 (3.4) 0.01 
Obesity, BMI ?30, % (n) 7.7 (532) 6.7 (53) 6.9 (85) 7.3 (99) 7.8 (146) 9.1 (149) 0.012 
Height cm (SD) 175.7 (6.3) 178.0 (6.1) 176.7 (6.2) 175.9 (6.3) 174.5 (6.1) 174.8 (6.4) <0.001 
Systolic blood pressure, 
mmHg, mean (SD)
149 (22) 145 (21) 148 (21) 149 (22) 150 (22) 148 (22) <0.001 
Diastolic blood pressure, 
mmHg, mean (SD)
95 (13) 93 (13) 94 (13) 95 (13) 95 (13) 94 (13) 0.022 
Hypertension, % (n) 70.0 (4802) 63.1 (500) 69.4 (854) 72.5 (976) 71.7 (1340) 69.7 (1132) 0.006 
Current smokers, % (n) 50.1 (3444) 47.2 (374) 45.9 (565) 49.8 (671) 51.1 (957) 53.8 (877) <0.001 
Sedentary, % (n) 25.3 (1716) 20.1 (159) 18.4 (226) 22.8 (308) 28.4 (532) 30.1 (491) <0.001 
Permanent stress*, % (n) 14.9 (966) 13.9 (110) 11.5 (141) 13.9 (187) 15.0 (281) 15.1 (247) 0.020 
BMI=body mass index. P-value for trends in distribution of baseline characteristics. *Self-perceived psychological stress category 3=permanent stress 
Table 4. Baseline characteristics according to occupational class
During a 35-year follow-up (median follow-up 28 years) 907 (13%) of the 6874 men 
were diagnosed with diabetes.
Table 5 shows the estimates of SHR for diabetes in the different occupational classes. 
In the age adjusted competing risk model there was a signifi cant higher SHR of diabe-
tes in the two lowest occupational classes compared to the highest occupational class 
(SHR 1.28 95% CI [1.01-1.64] and SHR 1.48 95% CI [1.16-1.89] for skilled workers 
and unskilled/semiskilled workers respectively). 
The SHR attenuated in the multiple adjusted model where we adjusted for conven-
tional risk factors for diabetes and psychological stress but SHR remained signifi -
cantly increased for unskilled and semiskilled workers also in this model (SHR 1.39 
95% CI [1.08-1.78]). 
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Occupational class Number 
at risk 
Diabetes
cases 
Diabetes cases
per 100,000 
person-years 
Age adjusted 
SHR 
(95% CI) 
Multivariable 
adjusted* SHR 
(95% CI) 
High officials, professionals 793 88 391 Ref ref 
Intermediate, non-manual 
employees 
1231 139 409 1.05 (0.80-1.37) 0.98 (0.75-1.29) 
Assistant non-manual 
employees 
1348 171 496 1.21 (0.92-1.58) 1.18 (0.90-1.54) 
Skilled workers 1871 255 530 1.28 (1.01-1.64) 1.18 (0.93-1.51) 
Unskilled and semiskilled 
workers 
1631 254 630 1.48 (1.16-1.89) 1.39 (1.08-1.78) 
Table 5. Age and multivariable-adjusted subdistributional hazard ratios (SHRs) and 95% confi -
dence intervals (CIs) of the incidence of diabetes in different occupational classes over a 35-year 
follow-up period
Figure 2 presents the cumulative incidence of diabetes and death across the occupa-
tional classes. As can be seen, the cumulative incidence of diabetes, when taking into 
account death as a competing event, gradually increased by decreasing occupational 
class with the lowest cumulative incidence among higher offi cials and professionals 
(11%) and the highest cumulative incidence among unskilled and semiskilled work-
ers (16%). Cumulative mortality was inversely related to occupational class with the 
highest death rate among unskilled and semiskilled workers (65%) and the lowest 
among higher offi cials and professionals (53%). 
Figure 2. Cumulative incidence curves of diabetes and mortality across the occupational 
classes.
*Adjusted for age, BMI, hypertension, smoking, physical activity and self-perceived psychological stress.
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Figure 3 shows the conditional probability of diabetes by occupational class when 
taking death from other causes into account. Under the condition that a participant did 
not die, the probability of diabetes after 35 years of follow-up was 43% for unskilled 
and semiskilled workers, 35% for skilled workers, 31% for assistant non-manual em-
ployees, 26% for intermediate non-manual employees, and 23% for high offi cials. 
Figure 3. Conditional probability of diabetes according to different occupational classes, 
taking death attributable to other causes into account.
Long-term excess risk of stroke in people with type 2 diabetes in 
Sweden according to blood pressure level: a population-based case-
control study
Here we wanted to estimate the excess risk of stroke for type 2 diabetes patients at 
different blood pressure levels compared to the risk in the general population.
Baseline characteristics for type 2 diabetes patients and controls are presented in Ta-
ble 6. Type 2 diabetes patients as a group had less education and were less often born 
in Sweden compared to controls. Among type 2 diabetes patients 64% used antihy-
pertensive treatment and baseline comorbidities (CHD, AF, HF) were more common 
among type 2 diabetes patients compared with controls. 
During a median follow-up of 4.0 years 19,548 (4.8%) out of 408,076 type 2 diabetes 
patients received a diagnosis of stroke. Among the controls, 61,690 out of 1,913,507 
(3.2%) received a diagnosis of stroke during a median follow-up of 4.1 years. 
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Controls
n=1,913,507
All type 2 diabetes 
n=408,076
Women 869,045 (45.4%) 182,486 (44.7%) 
Age, years (SD) 64.6 (12.5) 65.3 (12.6) 
Born in Sweden 1,673,823 (87.5%) 337,235 (82.6%) 
Education category   
Low 682,929 (36.3%) 175,217 (43.9%) 
Mid 744,627 (39.6%) 160,153(40.1%) 
High 453,805 (24.1%) 63,730 (16.0%) 
Registrations in the NPR† prior to baseline   
CHD§ (I20-I25) 137,957 (7.2%) 62,037 (15.2%) 
AF? (I48) 89,814 (4.7%) 32,166 (7.9%) 
HF¶ (I50) 53,104 (2.8%) 25,986 (6.4%) 
Variables in the NDR* only   
Systolic BP‡, mmHg (SD)   140.3 (18.3) n=351,847 
Diastolic BP‡, mmHg (SD)  78.6 (9.8) n=351,847 
HbA1c, mmol/mol (SD), NGSP % (SD)  54.3 (14.6), 6.3 (1.4) n=364,237
Diabetes duration, y (SD)  5.53 (6.96) n=363,024 
Antihypertensive treatment  245,495 (64.0%) 
Categorical variables are shown as n (%) and continuous variables are shown as mean (SD). †NPR=National Patient 
Register, §CHD=coronary heart disease, ?AF=atrial fibrillation, ¶HF=heart failure, *NDR=National Diabetes Register 
and ‡BP=blood pressure  
Table 6. Characteristics of people with type 2 diabetes at fi rst inclusion in the NDR, 1998-2011, 
and of controls, all free of previous stroke
The multiple adjusted HR (adjusted for updated age, sex, stratifi ed by diabetes dura-
tion, being born in Sweden, maximum education level and baseline comorbidities) of 
any stroke for type 2 diabetes patients as a group was 1.43 (95% CI 1.41-1.46) com-
pared with people without diabetes. Corresponding values for ischemic stroke and 
hemorrhagic stroke for type 2 diabetes patients as a group compared with the controls 
were 1.48 (95% CI 1.46-1.51) and 1.08 (95% CI 1.02-1.14) respectively. 
When estimating the multiple adjusted HR for any stroke in each blood pressure cat-
egory compared to the controls, we found a signifi cantly increased risk in the three 
highest blood pressure categories with HRs of 1.20 (95% CI 1.16-1.24), 1.47 (95% CI 
1.43-1.50), and 1.97 (95% CI 1.90-2.03) for blood pressure categories of 130-139/80-
89, 140-159/90-99, and ≥160/≥100 mmHg, respectively (Figure 4).
For ischemic stroke, the risk compared to the controls was signifi cantly increased also 
in blood pressure categories below 130/80, however only very slightly. For hemor-
rhagic stroke, type 2 diabetes patients in blood pressure categories 120-129/70-79 
mmHg and 130-139/80-89 mmHg had a signifi cantly decreased risk of hemorrhagic 
stroke compared with controls (multiple adjusted HRs of 0.66 (95% CI 0.55-0.79) and 
0.87 (95% CI 0.78-0.97), respectively).
Glycaemic control and excess risk of ischaemic and haemorrhagic 
stroke in patients with type 1 diabetes: a cohort study of 33,453 patients
In this study we wanted to estimate the excess risk of stroke in type 1 diabetes patients 
at different updated HbA1c categories compared to the general population.
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Figure 4. Adjusted hazard ratios of stroke and stroke subtypes by time updated blood 
pressure category. Hazard ratios (HR) and 95% confi dence intervals (CIs) were es-
timated by means of Cox regression adjusted for time-updated age, sex, stratifi ed 
by diabetes duration, being born in Sweden, maximum education level and baseline 
comorbidities (atrial fi brillation, coronary heart disease, and heart failure).
Patients with type 1 diabetes were more often born in Sweden, had more of the comor-
bidities AMI, CHD, HF and cancer at baseline compared to controls (Table 7). Within 
the group of patients with diabetes, diabetes duration, BMI and average systolic blood 
pressure initially increased by each higher HbA1c category and then decreased slight-
ly in the highest HbA1c categories. However, the difference in average blood pressure 
between the highest and lowest HbA1c category was only 2.6 mmHg for systolic and 
3.0 mmHg for diastolic blood pressure. The proportion of smokers and the presence 
of baseline comorbidities increased by higher HbA1c categories. 
During a mean follow-up of 7.9 years, 762 (2.3%) out of 33,453 type 1 diabetes pa-
tients received a diagnosis of stroke as compared with 1122 (0.7%) out of 159,924 
controls during a mean follow-up of 8.2 years. 
The Cox regression model adjusted for time-updated age, sex, stratifi ed by diabetes 
duration, maximum education category and baseline comorbidities (CHD and AF) 
showed that compared with controls, type 1 diabetes patients as a group had a HR of 
3.14 (95% CI 2.85–3.46) for any stroke, 3.29 (95% CI 2.96–3.66) for ischemic stroke 
and 2.49 (95% CI 1.96–3.16) for hemorrhagic stroke. 
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Table 8 shows the multiple adjusted HRs for stroke and subtypes of stroke over the 
HbA1c categories compared to the risk among the controls. For ischemic stroke, the 
risk was signifi cantly increased in all HbA1c categories and for hemorrhagic stroke 
it was increased in all but the lowest HbA1c category. The excess risk for any stroke 
ranged from a 75% increased risk in the lowest HbA1c category to an eight-fold in-
creased risk in the highest.
Table 8. Adjusted hazard ratios for stroke (and 95% confi dence intervals) for time-updated mean 
HbA1c categories versus population-based controls as examined by Cox regression
 
HR (95% CI)a 
P-value 
   HbA1c categories at baselineb  
 
Controls 
(reference)
?6.9% 
(?52 mmol/mol) 
7.0–7.8% 
(53–62 mmol/mol)
7.9–8.7% 
(63–72 mmol/mol)
8.8–9.6% 
(73–82 mmol/mol)
?9.7% 
(?83 mmol/mol) 
Stroke  
(events/individuals) 
1855/191,004 
1.00 1.74 (1.35–2.25)
<0.0001 
2.16 (1.83–2.55) 
<0.0001 
3.52 (3.08–4.03) 
<0.0001 
4.38 (3.67–5.21) 
<.0001 
7.98 (6.46–9.85)
<0.0001 
Ischaemic stroke  
(events/individuals)   
1544/191,004 
1.00 1.89 (1.44–2.47)
<0.0001 
2.20 (1.84–2.64) 
<0.0001 
3.82 (3.31–4.41) 
<0.0001 
4.57 (3.78–5.53) 
<0.0001 
7.94 (6.29–10.03)
<0.0001 
Haemorrhagic stroke  
(events/individuals)  
311/191,004 
1.00 1.10 (0.52–2.33)
0.81 
2.00 (1.34–3.00) 
0.0007 
2.19 (1.49–3.22) 
<0.0001 
3.52 (2.23–5.54) 
<0.0001 
8.17 (5.00–13.35)
<0.0001 
aHRs adjusted for time-updated age, sex, stratified by diabetes duration category, maximum educational level and baseline comorbidities (coronary heart 
disease and atrial fibrillation). bHbA1c categories expressed as % (mmol/mol), in accordance with the National Glycohemoglobin Standardization Program 
and International Federation of Clinical Chemistry and Laboratory Medicine, respectively. 
Figure 5. Adjusted hazard ratios (HRs) for stroke (and 95% confi dence intervals) for time-updated 
mean HbA1c categories stratifi ed by sex versus population-based controls as examined by Cox 
regression; adjusted for time-updated age, stratifi ed by diabetes duration, maximum educational 
level and baseline comorbidities (coronary heart disease and atrial fi brillation). HbA1c categories 
expressed as % in accordance with the National Glycohemoglobin Standardization Program.
Figure 5 shows the result from the Cox regression for any stroke subgroup by sex. 
There were no signs of interaction concerning sex. 
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DISCUSSION
Is high-normal blood pressure at mid-life a predictor of later develop-
ment of diabetes? (Paper I)
It is well known that type 2 diabetes and hypertension are two conditions that often 
co-exist (87) and persons with hypertension are more prone to develop diabetes (40). 
It has also been shown that persons with high-normal blood pressure have a higher 
risk of developing diabetes (41, 42). From the Framingham study (87) and a multitude 
of subsequent studies we know that risk factors in mid-life are important for long-term 
outcomes. However, not all risk factors persist as important risk factors at a prolonged 
follow-up. For example, data based on the Multifactor Primary Prevention study has 
shown that smoking, a strong risk factor for coronary heart disease after 10 years 
became less important and was no longer a signifi cant risk factor after 21 years (88).
In our study, the median follow-up was 28 years, and we found that high-normal sys-
tolic blood pressure in men at midlife indicated increased risk of later development of 
diabetes even at this prolonged follow-up. Blood pressure is a continuous variable and 
the defi nitions of what we call hypertension and high-normal blood pressure are not 
limits created by nature but arbitrary and made up by the medical profession. Since 
hypertension has been associated with an increased risk of diabetes it is easy to imag-
ine that high-normal blood pressure might also imply an increased risk of diabetes. 
Since an elevated blood pressure level remains a risk factor even after a prolonged 
follow-up it can be assumed that this is a process that starts many years before the de-
velopment of diabetes. One study of men who had developed diabetes at middle-age 
was found to have had signifi cantly higher blood pressure already in young adulthood 
compared to men who did not develop diabetes (39). Whether this applies to blood 
pressure measured in middle age and subsequent development of diabetes over an 
extended period has not been investigated. Changes in the microcirculation could be 
the common denominator for hypertension and type 2 diabetes since alteration in the 
microcirculation is known to precede both hypertension and type 2 diabetes (37, 38).
Some antihypertensive medications, chiefl y β-blockers and thiazide diuretics, have 
been recognized as potentially associated with an increased risk of diabetes (89). In 
our study, we adjusted for use of antihypertensive treatment at baseline but we had 
no information on medication during follow-up. However, even though certain anti-
hypertensive medications might marginally increase the risk of developing diabetes 
it has also been shown that the greatest risk of develop diabetes is associated with the 
existence of hypertension (40). 
Our study has shown that high-normal blood pressure indicates an increased risk of 
diabetes. In addition, other studies have shown that high-normal blood pressure indi-
cate increased risk of cardiovascular disease (90). Still, this cannot be taken to mean 
that we should consider to start antihypertensive treatment for persons with high-
normal blood pressure. The European Society of Hypertension (ESH) and European 
Society of Cardiology guidelines from 2007 (91) suggested that antihypertensive 
drug therapy should be introduced for patients with blood pressure in the high-normal 
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range if concomitant diabetes, cardiovascular disease or renal disease. However, the 
evidence in favor of this early intervention has been found to be weak (92). According 
to “2013 EHS/ESC Guidelines for the management of arterial hypertension”  lifestyle 
changes such as salt restriction, moderation of alcohol consumption, high consump-
tion of vegetables and fruits and other types of diet, weight reduction and regular 
physical activity (92) should be introduced in patients with high-normal blood pres-
sure but antihypertensive medications are not recommended. Lifestyle changes have 
been shown to reduce blood pressure (93) and are also factors that affect the risk of 
developing diabetes. In addition, smoking cessation should be advocated in order to 
reduce cardiovascular risk (92). 
To sum up, for people with high-normal blood pressure and their physicians, it is 
important to continue to monitor the blood pressure level as well as consider what 
lifestyles factors that could be modifi ed in order to prevent not only cardiovascular 
diseases but also diabetes. 
Were there differences in development of diabetes over the occupation-
al classes in Gothenburg and to what extent could they be explained by 
conventional risk factors and psychological stress? (Paper II)
Studies in high income countries with up to 15 years of follow-up have shown that 
people with low SEP are more affected by type 2 diabetes compared with people in 
higher SEP groups (46). A signifi cant proportion of this excess risk of diabetes is due 
to a greater prevalence of conventional risk factors for diabetes in lower SEP groups 
(94). Stress and other psychological factors have been suggested to account for some 
of the remaining excess risk of diabetes in lower SEP groups. Stress is a risk factor for 
type 2 diabetes (34) and lower SEP groups report a higher psychological burden (95). 
We found an inequality in the incidence of diabetes between different occupational 
classes among Swedish men and that this difference persists into older ages. Adjust-
ment for conventional risk factors for diabetes as well as stress attenuated the differ-
ence but a signifi cantly increased risk of diabetes persisted in the lowest occupational 
class compared to the highest. 
In our study we used occupation as an indicator of SEP. The indicator of SEP that has 
shown the strongest association with incidence of diabetes is education (46). It can be 
argued that education often tend to lead to higher occupational positions and in many 
cases higher income but it has been shown that the different indicators of SEP cannot 
be used interchangeably (96). The indicators represent different underlying pathways 
and causal mechanisms and are also said to represent different time-periods of the life. 
The only indicator of SEP available to us in our study was occupation. Since most 
studies have found a higher correlation between educational level and incidence of 
diabetes (46), we might potentially have found a stronger association to SEP if educa-
tion had been our indicator.
Even though permanent stress was somewhat more prevalent in lower SEP in our 
study, we could not fi nd that our indicator of stress could explain the difference in in-
cidence of diabetes over the SEP categories to any great extent. Psychological factors 
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are diffi cult to defi ne and to measure. Many different methods are in use to measure 
stress. We used a single question to estimate the amount of stress experienced by the 
participants. The same question has been used as a measurement of stress in large 
international studies such as INTERHEART (97) and INTERSTROKE (57). Even 
though this question showed strong correlation with other measurements of stress in 
the INTERHEART study (97), all aspects of stress and psychological burden experi-
enced will not have been captured. Previous studies have come to divergent fi ndings 
as to whether psychological aspects explain parts of the difference in incidence of 
diabetes across the SEP categories (95, 98). 
In our study, as well as in many other studies, there remains an increased risk of 
diabetes among persons in the lower SEP levels even after having accounted for con-
ventional risk factors. This remaining increase in risk for diabetes could have several 
causes. Psychological factors not captured as discussed above could contribute but 
also early life factors like prenatal and perinatal circumstances. Low birth weight and 
preterm birth have been found to be associated with later in life insulin resistance 
and increased risk of type 2 diabetes (99). At the period that the men in our study 
were born (1915-1925) the risk for the mothers of the men to be exposed to factors 
that might have an adverse infl uence on the fetus might very well have varied over 
the SEP categories. Also poor nutritional status during childhood has been associated 
with increased risk of later development of type 2 diabetes (100). Since it is common 
to adopt the same SEP as your parents (101) a greater proportion of men in lower SEP 
probably had parents in lower SEP. Therefore, more men in lower SEP might have en-
countered these adverse early life experiences making them more susceptible to later 
in life development of type 2 diabetes. 
A large proportion of the increased risk of diabetes in the lower occupational classes 
is explained by the conventional risk factors. This is important information in order to 
know where to direct preventive action most effectively. Even though these risk fac-
tors of course are important in all SEP, they are more prevalent in the lower SEP. In 
addition, different approaches might be needed to reach people with health behavior 
messages. Reducing inequality in health is an important issue not only to reduce cost 
for society but as a matter of letting more people achieve higher potential when it 
comes to health. 
What is the excess risk of stroke in type 2 diabetes patients at different 
blood pressure levels compared to the general population? (Paper III)
During the last decade there has been a discussion of what blood pressure level should 
be aimed at when treating the blood pressure in patients with diabetes in order to 
protect them from cardiovascular disease. In this article we did not aim at estimating 
the most optimal blood pressure target in type 2 diabetes patients but to estimate the 
excess risk of stroke at different blood pressure in relation to an age and sex matched 
general population.
We found, not unexpectedly, that type 2 diabetes patients as a group have an increased 
risk of any stroke compared to an age and sex matched general population. However, 
when we estimated the risk according to their updated blood pressure, the risk of 
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any stroke was not increased for type 2 diabetes patients with blood pressure below 
130/80 mmHg. The excess risk of ischemic and hemorrhagic stroke at different blood 
pressure levels in comparison with the risk of the general population was markedly 
dissimilar. For ischemic stroke, the risk was increased in relation to the general popu-
lation at all updated blood pressure levels, even though the risk was not increased to a 
great extent for blood pressure levels below 130/80. In contrast, for patients with type 
2 diabetes and blood pressure between 120-139/70-89 mmHg the risk of hemorrhagic 
stroke was signifi cantly reduced compared to the general population. 
Some previous studies have found type 2 diabetes to be a risk factor for hemorrhagic 
stroke (55, 56) even though not a very strong one. Other studies have not found hem-
orrhagic stroke or primary intracerebral hemorrhage to be more common among pa-
tients with than without diabetes (58). The large case-control study INTERSTROKE 
with more than 3000 intracerebral hemorrhages found a history of diabetes or HbA1c 
>6.5% to signifi cantly reduce the risk of intracerebral hemorrhage (52). Potentially, 
our fi nding of lower risk of hemorrhagic stroke among patients with type 2 diabetes 
except in those with high blood pressure could improve the understanding of the as-
sociation between diabetes and risk of hemorrhagic stroke. 
A protective role of diabetes has been suggested concerning the development of ab-
dominal aortic aneurysm (56, 102) and subarachnoid hemorrhage (56) since patients 
with diabetes seem to be spared with respect to those conditions. Diabetes has been 
associated with thicker extracellular matrix of the vessels and deposition of advanced 
glycation end products (AGEs) that induce cross linkage between components in the 
matrix, all enhancing the stiffness of the wall (102). One can only speculate if these 
mechanisms could be of importance concerning our fi nding of reduced risk of hemor-
rhagic stroke for patients with type 2 diabetes in the lower blood pressure categories. 
Another possible protective feature for patients with diabetes when it comes to hemor-
rhagic stroke is the lipid pattern. High LDL levels is common in patients with type 2 
diabetes (103) and high cholesterol and LDL levels have been associated with reduced 
risk of hemorrhagic stroke (104).      
Our fi nding of increased risk of ischemic stroke in all blood pressure categories com-
pared to the general population was perhaps more expected. This fi nding is in con-
cordance with the one other study we have found that has estimated the excess risk 
of stroke for diabetes patients at different blood pressure levels (55). In our study, a 
slight J-shaped association was found over the blood pressure categories concerning 
the risk of ischemic stroke compared to the general population with the lowest risk in 
category 120-129/70-79 mmHg. The same J-shaped association between blood pres-
sure and risk of ischemic stroke was also seen in our analysis within the group of type 
2 diabetes patients. The increased risk of ischemic stroke in category 110-119/65-69 
mmHg compared to category 120-129/70-79 mmHg can be caused by a greater num-
ber of people with a higher baseline risk of stroke in this category. Low blood pressure 
is often refl ective of poor health (105). The lower blood pressure categories com-
prised a larger proportion of patients with CHD, AF, and HF compared to the higher 
categories. Even though we adjusted for baseline comorbidities in our models, we 
cannot exclude the possibility of low blood pressure as an indicator of comorbidities, 
implying a higher stroke risk. A recent publication, also based on NDR data, points 
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out higher frequencies of comorbidities in the lowest blood pressure categories as re-
sponsible for the J-shaped association over the blood pressure categories and different 
cardiovascular out-comes (71). 
We believe that the estimates in our study on excess risk of stroke at different blood 
pressure levels can be of interest for both patients with type 2 diabetes and their phy-
sicians. Today, patients are often well informed and aware of the greater risk of car-
diovascular disease they face as a result of having type 2 diabetes. This study can 
encourage patients with type 2 diabetes in showing that they can have a risk of stroke 
comparable to the general population if their blood pressure is below 130/80. For 
physicians, information from this study can be a used as a motivator for patients with 
type 2 diabetes who might not be willing to start antihypertensive medication. Hy-
pertension is often asymptomatic but is still very important to treat in order to reduce 
morbidity and mortality in type 2 diabetes patients.
What is the excess risk of stroke for type 1 diabetes patients at different 
updated HbA1c levels compared to the general population? (Paper IV)
For long, HbA1c level in type 1 diabetes patients has been associated with risk of 
development of microvascular complications like nephropathy, retinopathy and neu-
ropathy (106). Lately, an increasing amount of studies has also linked HbA1c level 
in type 1 diabetes patients to macrovascular complications (62). Many studies at-
tempting to estimate the association between HbA1c and cardiovascular outcomes in 
type 1 diabetes patients have been relatively small, participants have been young and 
in combination with comparatively limited follow-up also had few events (61-63). 
Above all, this has been a problem regarding stroke events, in particular hemorrhagic 
stroke, which constitutes a minor part of the subtypes of stroke. 
In our study we followed a cohort of 33,453 type 1 diabetes patients with a baseline 
mean age of 36 years during a mean follow-up of approximately 8 years. During the 
follow-up 762 events of stroke were diagnosed. This is far more than most previous 
studies. We found an increased risk of ischemic stroke in all HbA1c categories com-
pared to persons without diabetes. For hemorrhagic stroke the risk was increased in all 
but the lowest HbA1c category. In addition, we found a correlation between HbA1c 
level and both subtypes of stroke with an increased risk of ischemic and hemorrhagic 
stroke by higher updated HbA1c levels compared to the controls. 
Previous studies have found HbA1c level to be a predictor of all and ischemic stroke 
(60, 62, 63). For hemorrhagic stroke, some studies have found elevated HbA1c to be 
a predictor (61) while others have not (60). Even if the number of hemorrhagic stroke 
cases in our lowest HbA1c category only was 5, the number increased in the higher 
HbA1c categories and the total number of hemorrhagic stroke in our study was 107. 
Higher HbA1c level indicated an increased risk of hemorrhagic stroke in the analysis 
comparing with the general population as well as in the analysis within the group of 
diabetes patients. In the analysis within the group of patients with type 1 diabetes we 
could adjust our models for several risk factors for stroke. An increased risk remained 
at least in the highest HbA1c category in all models. This suggests HbA1c as a predic-
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tor for hemorrhagic stroke even though maybe not as strong predictor as for ischemic 
stroke. 
Hypertension is an important risk factor for stroke (52). In the estimates of excess risk 
of stroke for type 1 diabetes patients compared to the general population we did not 
have blood pressure measurements of the controls and were thus unable to adjust for 
blood pressure. Hypertension is more common in people with type 1 diabetes than in 
people without diabetes (107). However, in our study the average blood pressure in 
the group of type 1 diabetes patients was 127/74 mmHg which is not very high. The 
difference in blood pressure between the lowest HbA1c category and the highest was 
only 2.4 mmHg for systolic and 3.0 mmHg for diastolic blood pressure. Still we found 
a difference in risk of stroke over the HbA1c categories. Additionally, in the analysis 
within the group of type 1 diabetes patients we could adjust for systolic blood pressure 
and we still saw an effect of HbA1c level on the risk of stroke. Therefore, it seems 
unlikely that blood pressure level could explain more than a minor part of the excess 
risk of stroke in patients with type 1 diabetes compared to the general population or 
the increase in risk of stroke by higher HbA1c category. 
Our fi nding of an increased risk of stroke among type 1 diabetes patients even with 
HbA1c levels within treatment target compared to an age matched general population 
can be discouraging. However, one must bear in mind that the absolute risk of stroke 
in this young population is low. Moreover, HbA1c level is important – the risk in-
creased from a 75% excess risk among the best controlled patients to an eightfold ex-
cess risk in the highest HbA1c category. Technological developments in recent years 
have resulted in new glucose monitoring utensils that can estimate glucose levels in 
the subcutaneous tissue like Continuous Glucose Monitoring (CGM) and Flash Glu-
cose Monitoring (FGM). These new utensils have shown being able to assist patients 
to achieve better HbA1c levels (108, 109). One drawback with these new utensils 
is the cost. However, the costs of complications of type 1 diabetes are large as well. 
A stroke in a young person living with possible lifelong sequelae are enormous, let 
alone loss of quality of life. Therefore, we believe that information from this study is 
important to further emphasize the importance of providing the best possible support 
for type 1 diabetes patients in order to keep as good glycemic control as possible.
Strengths and limitations
Strengths in Paper I and II include a large number of unselected participants from 
the general population, the prospective longitudinal design of the study, the extended 
follow-up and a large number of diabetes cases. 
The limitations in Paper I and II include several issues. First, the lack of blood glu-
cose samples or glucose tolerance test at the baseline examination is a limitation in 
that patients with undiagnosed diabetes might have been included among the partici-
pants. However, the majority of diabetes cases (approximately 90%) were detected 
more than a decade after the baseline screening. Therefore it seems unlikely that the 
number of undiagnosed diabetes cases at baseline would have affected our results 
in a signifi cant manner. Second, we captured a diagnosis of diabetes from hospital 
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discharge registers – not primary healthcare registers. Type 2 diabetes is often man-
aged at primary healthcare level, at least during the fi rst years, and participants with 
diabetes not hospitalized will be missed by our studies. However, due to the long 
follow-up, the majority of men did visit hospital at some point during the studies 
(approximately 95%). Diabetes is a condition affecting many other disorders and ac-
cordingly diabetes is likely to have been registered at least as a contributing diagnosis 
even though not being the primary reason why the participant was hospitalized. Men 
with diabetes managed in primary care only or who died without being hospitalized 
would, however, still have been missed. Finally, we only have access to baseline data 
of all the covariates. A study estimating secular trends in men aged 50 years between 
1963 and 1993 in Gothenburg showed that smoking rates, mean systolic blood pres-
sure and cholesterol level decreased while BMI and triglycerides increased during 
these 30 years (110). We do not know if these secular trends will have applied to the 
participants in our study but fl uctuations can occur in the covariates and we might not 
have captured the total effect of the covariates on the development of diabetes. 
The strengths in Paper III and IV are that they include a large number of patients with 
type 1 and type 2 diabetes respectively and the presence of a control group from the 
general population. The number of included patients with diabetes provided a large 
number of strokes, both ischemic and hemorrhagic, especially in the case of type 1 
diabetes patients, where there were more stroke cases than in any previous study. The 
data also represent diabetes patients on routine treatment in hospital or primary care 
centers nationwide and we had access to repeated measurements on several important 
risk factors in the group of diabetes patients. In addition we have information on co-
morbidities and education for both individuals with and without diabetes. 
However, there are also limitations to Paper III and IV. First, we did not have data on 
risk factors for the controls corresponding to the risk factor data we had in the group of 
diabetes patients. In Paper III, we did not have the blood pressure of the controls and 
therefore were unable to estimate the risk between patients with and without diabetes 
at every blood pressure level. The estimates of excess risk for type 2 diabetes patients 
at different blood pressure levels are estimates of excess risk compared to all controls 
pooled together as one reference group. Nor were we able to adjust the models for 
all the covariates that we had in the diabetes group since corresponding data were 
unavailable for the controls. However, we believe that the information of excess risk 
of stroke for type 2 diabetes patients estimated towards a sex and age matched general 
population may still be of interest. In Paper IV, concerning HbA1c level and stroke 
risk in type 1 diabetes patients, average blood pressure level was 127/74 mmHg in the 
group of diabetes patients, which is not very high. Moreover, we did have information 
on comorbidities of importance for the risk of stroke such as AF for both diabetes pa-
tients and controls. Smoking rates may be slightly lower among diabetes patients than 
in the general population. Taken together, we do not believe that information on these 
variables would have altered our results more than in a minor way. 
Second, during the fi rst years of the study the coverage of the NDR was incomplete, 
particularly for type 2 diabetes. Type 1 diabetes patients are, however, mainly man-
aged at hospital out-patient clinics and were reported to the NDR to a higher extent 
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from the outset. Primary care units where many of the type 2 diabetes patients are 
managed in the beginning started to report to the NDR at a later stage. However, a unit 
reporting their patients to NDR generally reports all their patients irrespective of how 
well controlled they are. Therefore we do not believe that the incomplete coverage of 
the NDR during the fi rst half of the study ought to have affected our results to a great 
extent. Third, the diagnosis of hemorrhagic and ischemic stroke are captured from 
registers, they were not formally validated. However, computed tomography scans are 
routinely used in all suspected stroke cases in Sweden which ought to minimize mis-
diagnosis. In our papers based on the NDR the proportion with hemorrhagic strokes 
was 9% in Paper III and 14% in Paper IV. RIKSTROKE, a quality register in Sweden 
where currently 90% of all stroke cases are registered, estimates that approximately 
10% of the strokes are intracerebral bleedings, 5% are subarachnoidal bleedings and 
85% are ischemic strokes (www.riksstroke.org/general-information). Therefore we 
believe that the classifi cation of subtypes of stroke refl ect the true situation among 
diabetes patients in Sweden. Finally, all our studies are observational and as for all ob-
servational studies we cannot totally exclude the possibility of residual confounders.  
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CONCLUSIONS
High-normal blood pressure as well as hypertension at midlife in men is a signifi cant 
risk factor of later development of type 2 diabetes even at a longer follow-up of 35 
years. The association between blood pressure level and risk of diabetes remained 
after adjustment for BMI and other conventional risk factors for diabetes. Also, low 
occupational class at midlife implies a signifi cantly increased risk of development of 
type 2 diabetes compared to higher occupational classes. The increased risk of diabe-
tes in the lower occupational classes is partly explained by an increased prevalence 
of conventional risk factors of type 2 diabetes. However, stress could not explain the 
difference over the occupational classes. 
On a group level, patients with type 2 diabetes have an excess risk of stroke com-
pared to a sex and age matched general population. The risk was noticeably higher 
for ischemic than for hemorrhagic stroke. However, when estimating the excess risk 
at different blood pressure levels we could not fi nd that type 2 diabetes patients with 
blood pressure below 130/80 mmHg had any increased risk of stroke compared to 
the general population. The slightly increased risk of ischemic stroke in lower blood 
pressure categories for diabetes patients was off-set by a signifi cantly reduced risk of 
hemorrhagic stroke.
Likewise, type 1 diabetes patients have an excess risk of stroke compared to the gen-
eral population, higher for ischemic than hemorrhagic stroke. The risk of any stroke 
was increased even in the group of type 1 diabetes patients with HbA1c within tar-
get. However, the risk rose considerably with worse metabolic control and elevated 
HbA1c therefore appears to be a risk factor for both ischemic and hemorrhagic stroke.
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